Photo: Kyphon and the X-STOP(R) IPD(R) Procedure to be Featured on American Health Radio on Monday, September 24, 2007
September 18 2007 - 4:15PM
PR Newswire (US)
New Minimally Invasive Procedure for Treating Major Symptoms of
Lumbar Spinal Stenosis SUNNYVALE, Calif., Sept. 18
/PRNewswire-FirstCall/ -- Kyphon Inc. (NASDAQ:KYPH) today announced
that Dr. Michael Marks, orthopaedic spine surgeon from Coastal
Orthopedics in Norwalk, Connecticut, and Julie Tracy, Kyphon's
chief communications officer, will be interviewed together on
American Health Radio, the nationally-syndicated health radio
program hosted by Scott Broder. The program will include questions
from listeners on the role of the X-STOP(R) Interspinous Process
Decompression (IPD(R)) procedure to treat the symptoms of lumbar
spinal stenosis. To view the Multimedia News Release, go to:
http://www.prnewswire.com/mnr/kyphon/29766/ During the show, Dr.
Marks will discuss the treatment options available to patients
suffering from lumbar spinal stenosis, including the X-STOP(R)
implant, the first interspinous process spacer approved in the U.S.
for treating the symptoms of lumbar spinal stenosis. Symptoms from
lumbar spinal stenosis often limit a patient's self-supporting
daily activities, work, and social and recreational pursuits. Using
a minimally invasive surgical procedure to place the X-STOP(R)
implant, symptoms may be relieved, and patients may return to a
more active lifestyle. The program will air live at 6:00 p.m.
Central Time on Monday, September 24, 2007 and can be accessed at
http://www.wrmn1410.com/. A replay of the program will be available
on Wednesday, September 26 at 8:00 p.m. Central Time and on Friday,
September 28 at 6:00 p.m. Central Time. Repeat broadcasts will also
be available at http://www.healthradionetwork.com/. About the
X-STOP(R) IPD(R) Procedure The X-STOP(R) IPD(R) procedure
represents a new approach to treating the symptoms of lumbar spinal
stenosis or LSS. LSS is a common spinal problem suffered mainly by
the middle-aged and elderly population and results from a narrowing
in the lumbar spinal canal that carries nerves to the legs. As this
space in the lower spine shrinks, nerves are squeezed causing
debilitating pain in the back and legs. The X-STOP(R) implant is
the first approved Interspinous Process Spacer in the U.S. to treat
the symptoms of LSS. It is designed to limit extension of the
lumbar spine and keep the canal open in the lower spine that
carries nerves to the legs thereby relieving pain associated with
the narrowing of the canal. The unique design of the X-STOP(R)
implant enables it to be inserted using a minimally invasive
approach, without fixation to bones or ligaments. Due to its
minimally invasive nature, the procedure can typically be performed
in 45 to 90 minutes. According to an independent market research
organization, there are approximately 1.4 million individuals in
the United States with a primary or secondary diagnosis of lumbar
spinal stenosis. The X-STOP(R) IPD(R) procedure may be a treatment
alternative for approximately 220,000 of these individuals who
would have otherwise been treated with conservative non-operative
therapies or with a surgical procedure called a laminectomy. About
Kyphon Inc. Kyphon develops and markets medical devices designed to
restore and preserve spinal function and diagnose the source of low
back pain using minimally invasive technologies. The company's
products are used in balloon kyphoplasty for the treatment of
spinal fractures caused by osteoporosis or cancer, in the
Functional Anaesthetic Discography(TM) (F.A.D.(TM)) procedure for
diagnosing the source of low back pain, and in the Interspinous
Process Decompression (IPD(R)) procedure for treating the symptoms
of lumbar spinal stenosis. More information about the company and
its products can be found at http://www.kyphon.com/ and its balloon
kyphoplasty patient education Web site,
http://www.spinalfracture.com/. Functional Anaesthetic Discography
and F.A.D. are trademarks, and Kyphon, X-STOP, and IPDare
registered trademarks, of Kyphon Inc.
http://www.prnewswire.com/mnr/kyphon/29766DATASOURCE: Kyphon Inc.
CONTACT: investors and media, Julie D. Tracy, Vice President, Chief
Communications Officer of Kyphon Inc., +1-408-548-6687 Web site:
http://www.kyphon.com/ http://www.wrmn1410.com/
http://www.healthradionetwork.com/ http://www.spinalfracture.com/
Copyright
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Jul 2024 to Aug 2024
Kyphon (MM) (NASDAQ:KYPH)
Historical Stock Chart
From Aug 2023 to Aug 2024